# MCM5

## Overview
The MCM5 gene encodes the minichromosome maintenance complex component 5, a protein integral to the DNA replication process. As part of the MCM2-7 complex, MCM5 functions as a DNA helicase, unwinding the DNA double helix at replication forks, which is essential for the initiation and progression of DNA replication. This protein is categorized as a helicase due to its role in DNA unwinding, a critical step in ensuring that replication occurs only once per cell cycle, thereby maintaining genomic stability (Kontos2012MCM5; Kearsey1998MCM). MCM5 is also involved in transcription regulation and chromatin dynamics, interacting with various proteins and complexes to modulate these processes. Its expression and interactions have significant implications in cancer biology, where alterations in MCM5 can influence drug resistance and prognosis (Wang2020MCM; Jiang2022lncRNA).

## Structure
The MCM5 protein is a component of the minichromosome maintenance (MCM) complex, which plays a crucial role in DNA replication. Structurally, MCM5 is part of the MCM2-7 complex, a hexameric assembly essential for helicase activity during DNA replication (Costa2009Structural). The protein contains an ATPase domain, which is part of the AAA+ superfamily, a highly conserved region critical for its function in DNA unwinding (Costa2009Structural).

The MCM5 protein undergoes several post-translational modifications, including phosphorylation, which is essential for regulating its activity throughout the cell cycle. Phosphorylation is mediated by CDKs and CDC7, and is regulated by ATM/ATR pathways (Li2019PostTranslational). Additionally, MCM5 can be modified by sumoylation and O-GlcNAcylation, which are involved in the regulation of DNA replication and response to DNA damage. Potential O-GlcNAcylation sites on MCM5 include T111, S135, S136, T476, S600, and S647 (Li2019PostTranslational).

The quaternary structure of MCM5 involves its assembly with other MCM proteins to form the MCM2-7 complex, which is crucial for its helicase function and interaction with DNA during replication (Costa2009Structural).

## Function
The MCM5 gene encodes a protein that is a crucial component of the minichromosome maintenance (MCM) complex, which plays a significant role in the initiation of DNA replication in healthy human cells. MCM5 is part of a heterohexameric complex that includes MCM2-7 proteins, functioning as a DNA helicase to unwind the DNA double helix at replication forks. This activity is essential for ensuring that DNA replication occurs only once per cell cycle, thereby maintaining genomic stability (Kontos2012MCM5; Kearsey1998MCM).

MCM5, along with MCM2 and MCM3, forms the peripheral subunits of the MCM complex, which regulate the active core subunits MCM4, MCM6, and MCM7. The MCM2-MCM5 dimer is thought to form a gate that regulates helicase activity and the loading of the complex onto replication origins (Kontos2012MCM5). MCM5 also interacts with CDC45, a molecule that regulates DNA replication initiation and elongation, and with the transcription factor STAT1a, suggesting a role in transcription regulation (Kontos2012MCM5).

In addition to its role in DNA replication, MCM5 is involved in transcription elongation by RNA polymerase II and interacts with histones H3 and H4, indicating its involvement in chromatin dynamics and gene expression regulation (Kontos2012MCM5).

## Clinical Significance
The MCM5 gene plays a significant role in various cancers due to alterations in its expression and interactions. In head and neck squamous cell carcinoma (HNSCC), the long non-coding RNA lnc-POP1-1 interacts with MCM5, promoting cisplatin resistance. This interaction prevents MCM5 ubiquitination and degradation, enhancing DNA repair and contributing to drug resistance (Jiang2022lncRNA). Overexpression of MCM5 in HNSCC cells increases resistance to cisplatin, while its downregulation sensitizes cells to the drug (Jiang2022lncRNA).

In gastrointestinal cancers, MCM5 serves as a prognostic marker, with its expression levels offering superior predictive potential compared to conventional markers like Ki-67 and PCNA. Alterations in MCM5 expression, such as gene amplification and mRNA upregulation, are common in gastric cancer and are associated with poor prognosis (Wang2020MCM). MCM5 is also implicated in resistance to chemotherapy and radiotherapy, with high expression levels correlating with shorter survival times in gastric adenocarcinoma patients (Wang2020MCM).

Overall, MCM5's role in cancer is linked to its involvement in DNA replication and repair processes, making it a potential target for therapeutic interventions aimed at overcoming drug resistance and improving cancer prognosis.

## Interactions
MCM5 is a component of the minichromosome maintenance (MCM) complex, which plays a crucial role in DNA replication. It forms a heterohexameric complex with other MCM proteins (MCM2-7), acting as a replicative helicase essential for DNA unwinding. MCM5 interacts directly with MCM3 and MCM2, forming a stable subcomplex within the larger MCM assembly (Crevel2001Nearest). These interactions are particularly strong on chromatin, suggesting a role in chromatin-associated DNA replication processes (Crevel2001Nearest).

MCM5 also participates in the formation of the CMG complex, which includes CDC45 and GINS, essential for replication fork progression (Meagher2022Two). The interaction with GINS and CDC45 is critical for the activation of the helicase activity necessary for DNA replication initiation and elongation (Meagher2019DNA).

In addition to its role in the MCM and CMG complexes, MCM5 interacts with prohibitin, a protein that modulates DNA replication. Prohibitin binds to MCM5 and MCM2, particularly during the G1 phase, suggesting a regulatory role in the replication machinery (Rizwani2009Prohibitin). These interactions highlight MCM5's multifaceted role in DNA replication and its regulation.


## References


[1. (Kontos2012MCM5) CK Kontos, MAS Pavlou, and C Giaginis. Mcm5 (minichromosome maintenance complex component 5). Atlas of Genetics and Cytogenetics in Oncology and Haematology, March 2012. URL: http://dx.doi.org/10.4267/2042/46072, doi:10.4267/2042/46072. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.4267/2042/46072)

[2. (Kearsey1998MCM) Stephen E. Kearsey and Karim Labib. Mcm proteins: evolution, properties, and role in dna replication. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1398(2):113–136, June 1998. URL: http://dx.doi.org/10.1016/s0167-4781(98)00033-5, doi:10.1016/s0167-4781(98)00033-5. This article has 372 citations.](https://doi.org/10.1016/s0167-4781(98)00033-5)

[3. (Li2019PostTranslational) Zheng Li and Xingzhi Xu. Post-translational modifications of the mini-chromosome maintenance proteins in dna replication. Genes, 10(5):331, April 2019. URL: http://dx.doi.org/10.3390/genes10050331, doi:10.3390/genes10050331. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes10050331)

[4. (Crevel2001Nearest) G. Crevel. Nearest neighbour analysis of mcm protein complexes in drosophila melanogaster. Nucleic Acids Research, 29(23):4834–4842, December 2001. URL: http://dx.doi.org/10.1093/nar/29.23.4834, doi:10.1093/nar/29.23.4834. This article has 30 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/29.23.4834)

[5. (Costa2009Structural) Alessandro Costa and Silvia Onesti. Structural biology of mcm helicases. Critical Reviews in Biochemistry and Molecular Biology, 44(5):326–342, September 2009. URL: http://dx.doi.org/10.1080/10409230903186012, doi:10.1080/10409230903186012. This article has 50 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/10409230903186012)

[6. (Wang2020MCM) Yifei Wang, Huarong Chen, Jinglin Zhang, Alfred S.L. Cheng, Jun Yu, Ka Fai To, and Wei Kang. Mcm family in gastrointestinal cancer and other malignancies: from functional characterization to clinical implication. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1874(2):188415, December 2020. URL: http://dx.doi.org/10.1016/j.bbcan.2020.188415, doi:10.1016/j.bbcan.2020.188415. This article has 37 citations.](https://doi.org/10.1016/j.bbcan.2020.188415)

[7. (Jiang2022lncRNA) Yingying Jiang, Haiyan Guo, Tong Tong, Fei Xie, Xing Qin, Xiaoning Wang, Wantao Chen, and Jianjun Zhang. Lncrna lnc-pop1-1 upregulated by vn1r5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with mcm5. Molecular Therapy, 30(1):448–467, January 2022. URL: http://dx.doi.org/10.1016/j.ymthe.2021.06.006, doi:10.1016/j.ymthe.2021.06.006. This article has 33 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.ymthe.2021.06.006)

[8. (Meagher2022Two) Martin Meagher, Alexander Myasnikov, and Eric J. Enemark. Two distinct modes of dna binding by an mcm helicase enable dna translocation. International Journal of Molecular Sciences, 23(23):14678, November 2022. URL: http://dx.doi.org/10.3390/ijms232314678, doi:10.3390/ijms232314678. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms232314678)

[9. (Meagher2019DNA) Martin Meagher, Leslie B. Epling, and Eric J. Enemark. Dna translocation mechanism of the mcm complex and implications for replication initiation. Nature Communications, July 2019. URL: http://dx.doi.org/10.1038/s41467-019-11074-3, doi:10.1038/s41467-019-11074-3. This article has 73 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-019-11074-3)

[10. (Rizwani2009Prohibitin) Wasia Rizwani, Mark G. Alexandrow, and Srikumar P. Chellappan. Prohibitin physically interacts with mcm proteins and inhibits mammalian dna replication. Cell Cycle, 8(10):1621–1629, May 2009. URL: http://dx.doi.org/10.4161/cc.8.10.8578, doi:10.4161/cc.8.10.8578. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/cc.8.10.8578)